Patient with catecholamine-secreting tumours due to RET and NF1 mutations secrete high levels of metanephrine, indicating epinephrine production in the tumour, while patients with mutations in the VHL gene exhibited an increased production of normetanephrine, indicating norepinephrine production. This evidence concerns the gene RET and neoplasm.